Taysha Gene Therapies (TSHA)
(Delayed Data from NSDQ)
$3.24 USD
+0.28 (9.46%)
Updated May 24, 2024 04:00 PM ET
After-Market: $3.23 -0.01 (-0.31%) 4:36 PM ET
3-Hold of 5 3
F Value B Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.10 | 8.06% |
Earnings Summary
For their last quarter, Taysha Gene Therapies (TSHA) reported earnings of -$0.10 per share, beating the Zacks Consensus Estimate of $-0.11 per share. This reflects a positive earnings surprise of 9.09%. Look out for TSHA's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.10 per share, reflecting a year-over-year increase of 73.68%.
Earnings History
Price & Consensus
Zacks News for TSHA
Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates
TSHA: What are Zacks experts saying now?
Zacks Private Portfolio Services